SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001666
Filing Date
2023-08-10
Accepted
2023-08-10 08:47:58
Documents
65
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vacc-20230630x10q.htm   iXBRL 10-Q 1639377
2 EX-31.1 vacc-20230630xex31d1.htm EX-31.1 13110
3 EX-31.2 vacc-20230630xex31d2.htm EX-31.2 13135
4 EX-32.1 vacc-20230630xex32d1.htm EX-32.1 7580
5 GRAPHIC vacc-20230630x10q001.jpg GRAPHIC 141505
  Complete submission text file 0001410578-23-001666.txt   5921393

Data Files

Seq Description Document Type Size
6 EX-101.SCH vacc-20230630.xsd EX-101.SCH 41332
7 EX-101.CAL vacc-20230630_cal.xml EX-101.CAL 49653
8 EX-101.DEF vacc-20230630_def.xml EX-101.DEF 191238
9 EX-101.LAB vacc-20230630_lab.xml EX-101.LAB 364177
10 EX-101.PRE vacc-20230630_pre.xml EX-101.PRE 265876
59 EXTRACTED XBRL INSTANCE DOCUMENT vacc-20230630x10q_htm.xml XML 746555
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Vaccitech plc (Filer) CIK: 0001828185 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40367 | Film No.: 231157386
SIC: 2834 Pharmaceutical Preparations